Regenerative Science™, Inc., founded in 2019 and headquartered in Manhattan Beach, Calif., is at the forefront of innovating novel treatments for complex ocular conditions.

Our amniotic membrane grafts maintain key growth factors, proteins and cytokines to support an ocular environment where wound healing can occur. Each is 100% amnion, bi-directional (either side can be placed on ocular surface), easy to handle and processed without the use of any chemical reagents.